ArticleCureus2026
Large Malignant Peripheral Nerve Sheath Tumor Arising From the Sciatic Nerve in a Patient With Neurofibromatosis Type 1.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are rare and aggressive soft tissue sarcomas arising from peripheral nerves or through the malignant transformation of preexisting benign nerve sheath tumors, particularly in patients with neurofibromatosis type 1 (NF1). Sciatic nerve involvement is uncommon and presents major diagnostic and surgical challenges because of the risk of significant functional impairment. A 21-year-old man with NF1 presented with a one-year history of a rapidly progressive right thigh mass associated with pain and severe motor deficit of the lower limb. Magnetic resonance imaging showed a large heterogeneous intramuscular mass in the posterior compartment of the right thigh, measuring 167 × 100 × 84 mm, with intratumoral necrotic areas and close continuity with the sciatic nerve. Core needle biopsy confirmed MPNST. After active bleeding developed at the biopsy site, urgent surgical resection was performed. Intraoperatively, the tumor was found to involve the sciatic nerve, particularly its common peroneal division, which required sacrifice during excision. A redundant plexiform neurofibroma on the medial aspect of the thigh was also excised separately. Histopathological examination confirmed the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade 3 MPNST with negative surgical margins. The patient subsequently received adjuvant radiotherapy and chemotherapy. At the two-year follow-up, there was no evidence of local recurrence or distant metastasis, and neurological status remained stable with rehabilitation. This case highlights the diagnostic complexity and surgical difficulty of giant sciatic nerve MPNST in a patient with NF1. Early recognition, complete surgical resection, and multidisciplinary management are essential to optimize oncologic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.